Report Detail
Global ADC Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4745531 |
- 28 September, 2026 |
- Global |
- 97 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global ADC Drug market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global ADC Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global ADC Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
Global ADC Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
Global ADC Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Bottles), and average selling prices (US$/Bottle), 2021-2032
Global ADC Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Bottles), and ASP (US$/Bottle), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for ADC Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global ADC Drug market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer Inc., Seagen, Roche, AstraZeneca, RemeGen Co., Ltd., Rakuten Medical, Gilead(Immunomedics), ADC Therapeutics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
ADC Drug market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
First Generation ADC Drug
Second Generation ADC Drug
Third Generation ADC Drug
Market segment by Application
Breast Cancer
Lymphoma
Leukemia
Other
Major players covered
Pfizer Inc.
Seagen
Roche
AstraZeneca
RemeGen Co., Ltd.
Rakuten Medical
Gilead(Immunomedics)
ADC Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe ADC Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of ADC Drug, with price, sales quantity, revenue, and global market share of ADC Drug from 2021 to 2026.
Chapter 3, the ADC Drug competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the ADC Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and ADC Drug market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of ADC Drug.
Chapter 14 and 15, to describe ADC Drug sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global ADC Drug Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 First Generation ADC Drug
- 1.3.3 Second Generation ADC Drug
- 1.3.4 Third Generation ADC Drug
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global ADC Drug Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Breast Cancer
- 1.4.3 Lymphoma
- 1.4.4 Leukemia
- 1.4.5 Other
- 1.5 Global ADC Drug Market Size & Forecast
- 1.5.1 Global ADC Drug Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global ADC Drug Sales Quantity (2021-2032)
- 1.5.3 Global ADC Drug Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Pfizer Inc.
- 2.1.1 Pfizer Inc. Details
- 2.1.2 Pfizer Inc. Major Business
- 2.1.3 Pfizer Inc. ADC Drug Product and Services
- 2.1.4 Pfizer Inc. ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Pfizer Inc. Recent Developments/Updates
- 2.2 Seagen
- 2.2.1 Seagen Details
- 2.2.2 Seagen Major Business
- 2.2.3 Seagen ADC Drug Product and Services
- 2.2.4 Seagen ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Seagen Recent Developments/Updates
- 2.3 Roche
- 2.3.1 Roche Details
- 2.3.2 Roche Major Business
- 2.3.3 Roche ADC Drug Product and Services
- 2.3.4 Roche ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Roche Recent Developments/Updates
- 2.4 AstraZeneca
- 2.4.1 AstraZeneca Details
- 2.4.2 AstraZeneca Major Business
- 2.4.3 AstraZeneca ADC Drug Product and Services
- 2.4.4 AstraZeneca ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 AstraZeneca Recent Developments/Updates
- 2.5 RemeGen Co., Ltd.
- 2.5.1 RemeGen Co., Ltd. Details
- 2.5.2 RemeGen Co., Ltd. Major Business
- 2.5.3 RemeGen Co., Ltd. ADC Drug Product and Services
- 2.5.4 RemeGen Co., Ltd. ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 RemeGen Co., Ltd. Recent Developments/Updates
- 2.6 Rakuten Medical
- 2.6.1 Rakuten Medical Details
- 2.6.2 Rakuten Medical Major Business
- 2.6.3 Rakuten Medical ADC Drug Product and Services
- 2.6.4 Rakuten Medical ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Rakuten Medical Recent Developments/Updates
- 2.7 Gilead(Immunomedics)
- 2.7.1 Gilead(Immunomedics) Details
- 2.7.2 Gilead(Immunomedics) Major Business
- 2.7.3 Gilead(Immunomedics) ADC Drug Product and Services
- 2.7.4 Gilead(Immunomedics) ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Gilead(Immunomedics) Recent Developments/Updates
- 2.8 ADC Therapeutics
- 2.8.1 ADC Therapeutics Details
- 2.8.2 ADC Therapeutics Major Business
- 2.8.3 ADC Therapeutics ADC Drug Product and Services
- 2.8.4 ADC Therapeutics ADC Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 ADC Therapeutics Recent Developments/Updates
3 Competitive Environment: ADC Drug by Manufacturer
- 3.1 Global ADC Drug Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global ADC Drug Revenue by Manufacturer (2021-2026)
- 3.3 Global ADC Drug Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of ADC Drug by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 ADC Drug Manufacturer Market Share in 2025
- 3.4.3 Top 6 ADC Drug Manufacturer Market Share in 2025
- 3.5 ADC Drug Market: Overall Company Footprint Analysis
- 3.5.1 ADC Drug Market: Region Footprint
- 3.5.2 ADC Drug Market: Company Product Type Footprint
- 3.5.3 ADC Drug Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global ADC Drug Market Size by Region
- 4.1.1 Global ADC Drug Sales Quantity by Region (2021-2032)
- 4.1.2 Global ADC Drug Consumption Value by Region (2021-2032)
- 4.1.3 Global ADC Drug Average Price by Region (2021-2032)
- 4.2 North America ADC Drug Consumption Value (2021-2032)
- 4.3 Europe ADC Drug Consumption Value (2021-2032)
- 4.4 Asia-Pacific ADC Drug Consumption Value (2021-2032)
- 4.5 South America ADC Drug Consumption Value (2021-2032)
- 4.6 Middle East & Africa ADC Drug Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global ADC Drug Sales Quantity by Type (2021-2032)
- 5.2 Global ADC Drug Consumption Value by Type (2021-2032)
- 5.3 Global ADC Drug Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global ADC Drug Sales Quantity by Application (2021-2032)
- 6.2 Global ADC Drug Consumption Value by Application (2021-2032)
- 6.3 Global ADC Drug Average Price by Application (2021-2032)
7 North America
- 7.1 North America ADC Drug Sales Quantity by Type (2021-2032)
- 7.2 North America ADC Drug Sales Quantity by Application (2021-2032)
- 7.3 North America ADC Drug Market Size by Country
- 7.3.1 North America ADC Drug Sales Quantity by Country (2021-2032)
- 7.3.2 North America ADC Drug Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe ADC Drug Sales Quantity by Type (2021-2032)
- 8.2 Europe ADC Drug Sales Quantity by Application (2021-2032)
- 8.3 Europe ADC Drug Market Size by Country
- 8.3.1 Europe ADC Drug Sales Quantity by Country (2021-2032)
- 8.3.2 Europe ADC Drug Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific ADC Drug Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific ADC Drug Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific ADC Drug Market Size by Region
- 9.3.1 Asia-Pacific ADC Drug Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific ADC Drug Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America ADC Drug Sales Quantity by Type (2021-2032)
- 10.2 South America ADC Drug Sales Quantity by Application (2021-2032)
- 10.3 South America ADC Drug Market Size by Country
- 10.3.1 South America ADC Drug Sales Quantity by Country (2021-2032)
- 10.3.2 South America ADC Drug Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa ADC Drug Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa ADC Drug Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa ADC Drug Market Size by Country
- 11.3.1 Middle East & Africa ADC Drug Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa ADC Drug Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 ADC Drug Market Drivers
- 12.2 ADC Drug Market Restraints
- 12.3 ADC Drug Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of ADC Drug and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of ADC Drug
- 13.3 ADC Drug Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 ADC Drug Typical Distributors
- 14.3 ADC Drug Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on ADC Drug. Industry analysis & Market Report on ADC Drug is a syndicated market report, published as Global ADC Drug Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of ADC Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
